LDN for Multiple sclerosis
MS is a long-lasting disease that can affect your brain, spinal cord, and the optic nerves in your eyes. It can cause problems with vision, balance, muscle control, and other basic body functions. The effects are often different for everyone who has the disease. Some people have mild symptoms and don’t need treatment. MS happens when your immune system attacks a fatty material called myelin, which wraps around your nerve fibers to protect them. Without this outer shell, your nerves become damaged. Scar tissue may form.
- Low dose naltrexone therapy in multiple sclerosis.
- A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis
- The effect of low-dose naltrexone on quality of life of patients with multiple sclerosis
- Pilot trial of low-dose naltrexone and quality of life in multiple sclerosis.
- Premature immunosenescence in rheumatoid arthritis and multiple sclerosis patients.
- Prevention and diminished expression of experimental autoimmune encephalomyelitis by low dose naltrexone (LDN) or opioid growth factor (OGF) for an extended period: Therapeutic implications for multiple sclerosis.
- The effect of low-dose naltrexone on quality of life of patients with multiple sclerosis: a randomized placebo-controlled trial.
- Low Dose Naltrexone in the treatment of inflammtory degenerative disease in the neuromuscular system including the amyotrophic lateral sclerosis, parkinson's disease, alzheimers, and muscular dystrophy.
"The use of low doses of naltrexone for the treatment of multiple sclerosis (MS) enjoys a worldwide following amongst MS patients. There is overwhelming anecdotal evidence, that in low doses naltrexone not only prevents relapses in MS but also reduces the progression of the disease. It is proposed that naltrexone acts by reducing apoptosis of oligodendrocytes. It does this by reducing inducible nitric oxide synthase activity. This results in a decrease in the formation of peroxynitrites, which in turn prevent the inhibition of the glutamate transporters" - Low dose naltrexone therapy in multiple sclerosis.